Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...
As climate change brings longer droughts, more frequent heat waves and increasingly unpredictable growing conditions to ...
Biotech is having a moment, and the numbers are hard to ignore. The SPDR S&P Biotech ETF (NYSEARCA:XBI) climbed 17.27% over ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
China and Hong Kong stocks rose on Monday as signs emerged that investor enthusiasm for artificial intelligence was ...
Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...
The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...
Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...
It might pull it off, provided several things fall right in place.
Investor's Business Daily on MSN
Why this biotech, up 14% since its breakout, is on the rise once again
Pharvaris stock jumped early Monday, but closed down, after the FDA agreed to review the company's treatment for a serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results